Stratos Genomics
Roche Acquires Sequencing Company Stratos Genomics
Roche said the acquisition is expected to advance development of its nanopore sequencer by providing access to Stratos' Sequencing by Expansion chemistry.
Stratos Genomics Raises $20M to Prep Sequencing Technology for Commercialization
The firm said recent breakthroughs in its technology will enable sequencing "at commercially compelling levels of read length, accuracy, process speed, and workflow efficiency."
Stratos Hits Milestone, Raises $15M from Roche, Fisk Ventures to Complete Series B Financing
Stratos reached its milestone by demonstrating nanopore sequencing with its proprietary expandable nucleotides, called X-NTPs.
Roche Execs Map Out Broad MDx Strategy at AACC Meeting
CHICAGO (GenomeWeb) — Roche Diagnostics this week provided a window into its business strategy, particularly in the area of molecular diagnostics where, over the last several months, the company has made a number of moves designed to position itself as "the most comprehensive provider of solution
Roche Invests up to $15M in Stratos Genomics for Nanopore Tech; Sees Synergy with Recent Genia Buy
Premium
NEW YORK (GenomeWeb) – When Roche announced last month that it planned to acquire nanopore sequencing startup Genia for up to $350 million, unbeknownst to the public